Related Experiment Video
Updated: Feb 23, 2026

Modeling Colitis-Associated Cancer with Azoxymethane AOM and Dextran Sulfate Sodium DSS
Published on: September 11, 2012
Role of SMAD proteins in colitis-associated cancer: from known to the unknown
P Chandrasinghe1,2,3, B Cereser1, M Moorghen2
1Department of Surgery and Cancer, Imperial College London, London, UK.
Abstract:
Small mothers against decapentaplegic (SMAD) proteins are a family of signal transduction molecules in transforming growth factor β (TGFβ) ligand pathways that have been found to have a key role in the pathogenesis of inflammatory bowel disease (IBD). Long standing IBD predisposes individuals to colitis-associated colorectal cancer (CAC), an entity that possess unique characteristics compared to hereditary and sporadic cancer. The ligands of the TGFβ super family along with SMADs have also been implicated in several aspects of colorectal cancer formation. SMAD proteins are shown to be involved in a number of potentially carcinogenic mechanisms such as altering gene transcription, controlling stem cell differentiation to causing epigenetic changes. Modulation of these proteins has emerged as a novel therapeutic intervention for IBD although its effect on carcinogenesis remains elusive. This account reviews available evidence linking SMAD proteins to CAC and explores the potential areas for future research in this area.
Insights
Small mothers against decapentaplegic (SMAD) proteins are crucial in inflammatory bowel disease (IBD) and colitis-associated colorectal cancer (CAC). Research is exploring SMADs
Area of Science:
- Molecular biology
- Gastroenterology
- Oncology
Background:
- Small mothers against decapentaplegic (SMAD) proteins are key signal transducers in transforming growth factor β (TGFβ) pathways.
- Chronic inflammatory bowel disease (IBD) increases the risk of colitis-associated colorectal cancer (CAC).
- SMAD proteins and TGFβ superfamily ligands are implicated in colorectal cancer development.
Purpose of the Study:
- To review the evidence linking SMAD proteins to colitis-associated colorectal cancer (CAC).
- To explore the role of SMAD proteins in CAC pathogenesis.
- To identify future research directions regarding SMADs in CAC.
Main Methods:
- Literature review of existing studies on SMAD proteins, IBD, and CAC.
- Analysis of the molecular mechanisms by which SMADs influence carcinogenesis.
- Synthesis of current knowledge on therapeutic modulation of SMADs in IBD and its implications for cancer.
Main Results:
- SMAD proteins are involved in critical carcinogenic processes, including gene transcription alteration, stem cell differentiation control, and epigenetic modifications.
- The precise impact of therapeutic modulation of SMADs for IBD on CAC development is not yet fully understood.
- Evidence suggests a significant role for SMADs in the unique characteristics of CAC.
Conclusions:
- SMAD proteins are central to both IBD pathogenesis and the development of CAC.
- Further research is needed to elucidate the dual role of SMADs and to guide therapeutic strategies.
- Understanding SMADs' function in CAC is crucial for developing effective treatments for IBD patients at risk of cancer.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Abnormal Proliferation
Canonical Wnt Signaling Pathway
Cancer Cell Migration through Invadopodia

